Khaitan & Co advised Insight Venture Management LLC on India leg of global transaction for acquisition of majority equity stake in Brydon Sigala 1, LLC (ultimate holding company of Renesan Software) in one or more tranches, including the indirect acquisition of the Indian subsidiary namely, Renesan Software India Pvt Ltd.
Khaitan & Co advised Arch Capital Services LLC in relation to setting up its “global capabilities centres” in India at Trivandrum and Pune, through its newly incorporated entity i.e., Arch Global Services (India) Pvt Ltd.
Khaitan & Co advised The University of Tokyo Edge Capital Partners Company Ltd (UTEC) in connection with fund raise by Maieutic Semiconductors Pvt Ltd ("Company") by way of primary issuance in the series seed funding round led by The University of Tokyo Edge Capital Partners, Japan, along with participation from Indian venture capital firms Endiya Partners and Exfinity Venture Partners.
Khaitan & Co advised RPSG Ventures Ltd in strategic partnership with Falguni Shane Peacock (FSP), one of India’s most iconic luxury fashion houses.
Founded by Falguni Peacock and Shane Peacock, FSP has grown into a luxury couture house celebrated for its intricate craftsmanship, couture sensibility, and distinctive design language. Deeply rooted in India’s cultural heritage, the brand has consistently taken Indian couture to the world—dressing global icons, shaping red-carpet moments, and redefining modern luxury from an Indian lens.
Khaitan & Co acted as co-counsel to Kotak Life Sciences Fund I and Asha Ventures Fund I, in connection with their investment in Mediversal Healthcare Pvt Ltd (“Mediversal”), comprising an investment of aggregate ~USD 5.6 million by Kotak Life Sciences Fund I and by Asha Ventures Fund I.
The Firm role includes conducting legal due diligence, and drafting, negotiating, and finalizing the transaction documents, as well as advising on signing and closing actions.
Khaitan & Co advised Nectar Lifesciences Ltd (Nectar) in relation to sale of business of manufacturing, distribution, marketing and sale of active pharmaceutical ingredients and formulations of the Nectar to Ceph Lifesciences Pvt Ltd (“Purchaser”), as a slump sale on a going concern basis; and sale, transfer and delivery of the assets of Nectar in relation to its menthol business (“Assets”) to Purchaser.
The firm advised Nectar on all legal aspects of the transaction including the structuring and documentation for the transaction.
Khaitan & Co advised along with Debevoise & Plimpton, Canada-based Manulife in relation to its investment in a 50-50 greenfield life insurance joint venture in India with Mahindra & Mahindra Ltd subject to regulatory approval. Both JV partners have made a capital commitment to infuse a total of INR 7,200 crores (~ USD 800 million) in the insurance JV within first 10 years of its incorporation.
Khaitan & Co (the “Firm”) acted as legal advisors to JSW Paints Ltd (“Issuer”), part of the JSW Group, in relation to its acquisition finance and maiden issuance of listed, rated, unsecured, redeemable, non-convertible debentures aggregating to INR 3,300 crores (“NCDs”). The proceeds of the NCDs are proposed to be utilised towards, inter alia, funding the acquisition of shares of Akzo Nobel India Ltd by the Issuer.
Khaitan & Co acted as the lender's legal counsel to Hero FinCorp Ltd in respect of a structured rupee term loan facility aggregating to INR 200,00,00,000 (Indian Rupees Two Hundred Crores Only) extended to a Large Renewables Platform.
Khaitan & co advised Springline Advisory on its India entry and acquisition of business from Infinity Globus Accountant Pvt Ltd and Smart Accountants Services LLP.
